CONMED CNMD Net debt / EBITDA

Net debt / EBITDA at other companies

Johnson & JohnsonJNJ

0.8×-0.3×

StrykerSYK

1.9×-1.3×

Boston ScientificBSX

-0.1×-2.9×

VericelVCEL

-1×-3.1×

OSI SystemsOSIS

2.7×+1.1×

Zimmer Biomet HoldingsZBH

3.1×0.0×

FAQ

What is CONMED's net debt / EBITDA?

CONMED (CNMD) reported net debt / EBITDA of 6.1× in Q2 2026.

How has CONMED's net debt / EBITDA changed year-over-year?

CONMED's net debt / EBITDA increased by 60.0% year-over-year, from 3.8× to 6.1×.

What is the long-term trend for CONMED's net debt / EBITDA?

Over 5 years (2020 to 2025), CONMED's net debt / EBITDA has grown at a -6.9% compound annual growth rate (CAGR), from 7.8× to 5.5×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.